Jay M. Short - Nov 29, 2021 Form 4 Insider Report for BioAtla, Inc. (BCAB)

Role
Chief Executive Officer, Director, 10%+ Owner
Signature
/s/ Christian Vasquez, as Attorney-in-Fact for Jay M. Short
Stock symbol
BCAB
Transactions as of
Nov 29, 2021
Transactions value $
-$368,742
Form type
4
Date filed
12/6/2021, 07:41 PM
Previous filing
Nov 30, 2021
Next filing
Dec 7, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BCAB Common Stock Sale -$369K -15.4K -1.12% $23.89* 1.37M Nov 29, 2021 Direct F1, F2
holding BCAB Common Stock 794K Nov 29, 2021 By Spouse
holding BCAB Common Stock 259K Nov 29, 2021 By Carolyn Short 2020 Irrevocable Gift Trust
holding BCAB Common Stock 259K Nov 29, 2021 By Jay Short 2020 Irrevocable Gift Trust
holding BCAB Common Stock 302K Nov 29, 2021 By Capia IP, LLC
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of the Issuer's common stock sold by the reporting person to cover taxes due upon the release and settlement of the vested RSUs.
F2 The range of prices for the shares of Common Stock is from $23.75 to $24.11. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price.